Fig. 1From: Optimizing interleukin-2 concentration, seeding density and bead-to-cell ratio of T-cell expansion for adoptive immunotherapyThe microscopic view of PBMCs on day 0 (a) and the expanded T cells on day 3 (b). After activation with anti-CD2/CD3/CD28 coated beads, cell sizes considerably increasedBack to article page